Subscribe To
KTTA / Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference
Content Topics
Pasithea
Therapeutics
Participate
Wainwright
25th
Annual
Global
Investment
Conference
Stock
KTTA
KTTA News
By GlobeNewsWire
September 7, 2023
Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference
-- Attendees may request 1 x 1 meeting with management at [email protected] -- PALO ALTO, Calif. and MIAMI, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) more_horizontal
By Benzinga
October 11, 2021
Biotech Company Pasithea Therapeutics Teams Up With Evotec to Aid Mental Health Drug Discovery
Photo by CDC on Unsplash Pasithea Therapeutics ( NASDAQ: KTTA), a Florida-based biotechnology company, has teamed with life sciences company Evotec SE more_horizontal
By Benzinga
October 11, 2021
Biotech Company Pasithea Therapeutics Teams Up With Evotec to Aid Mental Health Drug Discovery
Photo by CDC on Unsplash Pasithea Therapeutics ( NASDAQ: KTTA), a Florida-based biotechnology company, has teamed with life sciences company Evotec SE more_horizontal
By Benzinga
October 11, 2021
Biotech Company Pasithea Therapeutics Teams Up With Evotec to Aid Mental Health Drug Discovery
Photo by CDC on Unsplash Pasithea Therapeutics ( NASDAQ: KTTA), a Florida-based biotechnology company, has teamed with life sciences company Evotec SE more_horizontal
By Benzinga
October 11, 2021
Pasithea, Evotec Ink Drug Development Pact
Pasithea Therapeutics Corp (NASDAQ: KTTA) has initiated a new chemical entity development program and named Evotec SE (OTC: EVOTF) its research more_horizontal
By Benzinga
October 11, 2021
Pasithea, Evotec Ink Drug Development Pact
Pasithea Therapeutics Corp (NASDAQ: KTTA) has initiated a new chemical entity development program and named Evotec SE (OTC: EVOTF) its research more_horizontal
By Benzinga
October 11, 2021
Pasithea, Evotec Ink Drug Development Pact
Pasithea Therapeutics Corp (NASDAQ: KTTA) has initiated a new chemical entity development program and named Evotec SE (OTC: EVOTF) its research more_horizontal